The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
The Oxidation of Lipoproteins by Monocytes-Macrophages
Open accessAbstract
low density lipoprotein ceruloplasmin endothelial cell interferon lipoxygenase lipopolysaccharide myeloperoxidase superoxide anion oligodeoxyribonucleotide(s) nitrogen monoxide (nitric oxide) protein kinase C conventional PKC cytosolic phospholipase A2 phorbol myristate acetate smooth muscle cell opsonized zymosan The oxidation of lipoproteins has been proposed as a biological process that initiates and accelerates arterial lesion development (1Chisolm G.M. Penn M.S. Fuster V. Ross R. Topol E.J. Oxidized Lipoproteins and Atherosclerosis. Raven Press, New York1996: 129-149Google Scholar, 2Steinberg D. J. Biol. Chem. 1997; 272: 20963-20966Abstract Full Text Full Text PDF PubMed Scopus (1407) Google Scholar, 3Berliner J.A. Navab M. Fogelman A.M. Frank J.S. Demer L.L. Edwards P.A. Watson A.D. Lusis A.J. Circulation. 1995; 91: 2488-2496Crossref PubMed Google Scholar, 4Witztum J.L. Horkko S. Ann. N. Y. Acad. Sci. 1997; 811: 88-99Crossref PubMed Scopus (45) Google Scholar, 5Heinecke J.W. Atherosclerosis. 1998; 141: 1-15Abstract Full Text Full Text PDF PubMed Google Scholar). Oxidized lipoproteins accumulate in lesions (6Yla-Herttuala S. Curr. Opin. Lipidol. 1998; 9: 337-344Crossref PubMed Scopus (93) Google Scholar) and may form at other inflammatory sites. Whether the oxidized lipoprotein is an initiator or accelerator of disease is the subject of speculation, debate, and intensive study. Various cellular and biochemical mediators of lipoprotein oxidation in vivo have been proposed, but none has yet been proven to be responsible.Two decades ago we demonstrated that low density lipoprotein (LDL),1 the plasma level of which correlates with the risk of atherosclerosis, could injure endothelial cells (ECs) in culture (7Hessler J.R. Robertson Jr., A.L. Chisolm G.M. Atherosclerosis. 1979; 32: 213-229Abstract Full Text PDF PubMed Scopus (389) Google Scholar). The capacity of LDL to injure cells was directly related to the level of LDL oxidation, and we speculated on a possible role for oxidized LDL-mediated endothelial injury in atherogenesis (8Hessler J.R. Morel D.W. Lewis L.J. Chisolm G.M. Arteriosclerosis. 1983; 3: 215-222Crossref PubMed Google Scholar, 9Morel D.W. Hessler J.R. Chisolm G.M. J. Lipid Res. 1983; 24: 1070-1076Abstract Full Text PDF PubMed Google Scholar). Contemporaneously, Dr. Daniel Steinberg's group (10Henriksen T. Mahoney E.M. Steinberg D. Arteriosclerosis. 1983; 3: 149-159Crossref PubMed Google Scholar, 11Henriksen T. Mahoney E.M. Steinberg D. Proc. Natl. Acad. Sci. U. S. A. 1981; 78: 6499-6503Crossref PubMed Google Scholar) demonstrated that LDL exposed to cultured ECs was altered such that it became a ligand for scavenger receptors. In 1984, both Steinberg's group and ours (12Steinbrecher U.P. Parthasarathy S. Leake D.S. Witztum J.L. Steinberg D. Proc. Natl. Acad. Sci. U. S. A. 1984; 81: 3883-3887Crossref PubMed Google Scholar, 13Morel D.W. DiCorleto P.E. Chisolm G.M. Arteriosclerosis. 1984; 4: 357-364Crossref PubMed Google Scholar) demonstrated that the “EC-modified LDL” they had characterized and the “oxidized LDL” we had described were the same entity. Their report highlighted the macrophage recognition of the EC-oxidized lipoprotein, and ours the capacity of EC or smooth muscle cell (SMC)-oxidized LDL to injure cells. These papers introduced the concept that reactive oxygen species from vascular cells could transform LDL, causing it to exhibit dramatically altered composition and atherogenic properties. The first demonstration that certain leukocyte populations could oxidize LDL employed human neutrophils and activated populations of adherent human monocytes, cells well known to generate abundant reactive oxygen species in vitro and in vivo (14Cathcart M.K. Morel D.W. Chisolm G.M. J. Leukocyte Biol. 1985; 38: 341-350Crossref PubMed Scopus (405) Google Scholar).The identity of the cells responsible for the oxidation of LDL that accumulates in lesions is uncertain. Although it is well known that free ferrous or cupric ions catalyze lipid in the of free ions in vivo is A.J. J. 1995; PubMed Google Scholar). in vivo for free A.J. J. 1995; PubMed Google Scholar, R. T. PubMed Google Scholar, PubMed Google Scholar). In we the that to the in vivo oxidation of they in arterial known to generate reactive oxygen EC and (12Steinbrecher U.P. Parthasarathy S. Leake D.S. Witztum J.L. Steinberg D. Proc. Natl. Acad. Sci. U. S. A. 1984; 81: 3883-3887Crossref PubMed Google Scholar, J.W. A. J. 1984; PubMed Google in vitro of LDL oxidation in free of In vitro LDL to be oxidized with the LDL Steinberg D. J. Lipid Res. Full Text PDF PubMed Google Scholar, M.K. Chisolm G.M. J. Lipid Res. 1995; Full Text PDF PubMed Google Scholar, M. M. J. Lipid Res. Full Text PDF PubMed Google Scholar). which may LDL In we cellular and for LDL the as a to in vitro on monocytes, and cell of of free or ions in vivo is but an concept in oxidation of LDL was The the that the plasma ceruloplasmin for as an could as a of LDL Chisolm G.M. J
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
Eiserich, J. P., Hristova, M., Cross, C. E., Jones, A. D., Freeman, B. A., Halliwell, B., & van der Vliet, A. (1998) · Nature · doi:10.1038/34923 · Cited by 1,496
Daugherty, A., Dunn, J. L., Rateri, D. L., & Heinecke, J. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117342 · Cited by 1,269
Hazen, S. L., & Heinecke, J. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119379 · Cited by 842
Self-citationFormation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite
van der Vliet, A., Eiserich, J. P., Halliwell, B., & Cross, C. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7617 · Cited by 780
Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
Hazell, L. J., Arnold, L., Flowers, D., Waeg, G., Malle, E., & Stocker, R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118576 · Cited by 592
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice
Cyrus, T., Witztum, J. L., Rader, D. J., Tangirala, R., Fazio, S., Linton, M. F., & Funk, C. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5897 · Cited by 523
Biological aspects of reactive nitrogen species
Patel, R. P., McAndrew, J., Sellak, H., White, C. R., Jo, H., Freeman, B. A., & Darley-Usmar, V. M. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00028-6 · Cited by 498
Hazell, L. J., van den Berg, J. J. M., & Stocker, R. (1994) · Biochemical Journal · doi:10.1042/bj3020297 · Cited by 267
Thomas, C. E. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90256-u · Cited by 67
Cited by
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Myeloperoxidase: friend and foe
Klebanoff, S. J. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1204697 · Cited by 2,282
Jia, Q.-W., Chen, Z.-H., Ding, X.-Q., Liu, J.-Y., Ge, P.-C., An, F.-H., Li, L.-H., Wang, L.-S., Ma, W.-Z., Yang, Z.-J., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000478071 · Cited by 1,691
Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease
Zhang, R. (2001) · JAMA · doi:10.1001/jama.286.17.2136 · Cited by 918
The oxidative modification hypothesis of atherogenesis: an overview
Chisolm, G. M., & Steinberg, D. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00344-0 · Cited by 746
Self-citation
Metadata
- Authors
- Chisolm, G. M., Hazen, S. L., Fox, P. L., & Cathcart, M. K.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-09
- Volume
- 274
- Issue
- 37
- Pages
- 25959-25962
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2142008513
- Cited by
- 174
- References
- 10
- FWCI
- 5.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.